Diagnostics, Biomarkers & Liquid Biopsy This slice is part of the broader Healthcare & Biotech theme.
Diagnostics, Biomarkers & Liquid Biopsy names often move on drivers that differ from the rest of Healthcare & Biotech. Isolating this segment keeps earnings logic and news flow aligned with one part of the value chain.
Membership is based on Next Big Trend classification under Healthcare & Biotech → Diagnostics, Biomarkers & Liquid Biopsy. Save the list as a watchlist to track updates without rebuilding Screener filters.
| Company | |||||||
|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $180.3B | +2.15% | -3.64% | -19.60% | -24.64% | 58 |
| IDXX | IDEXX Laboratories, Inc. | $41.2B | -0.08% | +2.26% | -23.43% | -17.77% | 75 |
| DGX | Quest Diagnostics Incorporated | $26.2B | -1.01% | -0.07% | +34.84% | +29.35% | 67 |
| CRL | Charles River Laboratories International, Inc. | $14.0B | +4.00% | +10.55% | +51.29% | +73.97% | 88 |
| RDY | Dr. Reddy's Laboratories Ltd | $10.4B | +1.88% | +6.58% | -10.48% | -10.16% | 83 |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | -0.81% | -0.70% | +20.85% | +20.91% | 65 |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.8B | 0.00% | 0.00% | +17.50% | +28.15% | 73 |
| CHRN | ChronoScale Holdings Corporation | $2.9B | -3.23% | +3.45% | +115.16% | +77.66% | 60 |
| FRNM | Freenome, Inc. | $1.7B | -3.31% | +6.69% | +21.11% | +48.87% | 83 |
| XGN | Exagen Inc. | $198M | +3.06% | +20.80% | +38.49% | -23.18% | 93 |
| LUCD | Lucid Diagnostics Inc. | $121M | +1.71% | -20.66% | -41.47% | -47.70% | 24 |
| IMDX | Insight Molecular Diagnostics Inc. | $117M | -2.03% | -15.33% | -55.07% | -8.42% | 33 |
| QUCY | Quantum Cyber N.V. | $108M | +1.50% | -1.46% | -87.02% | -90.92% | 63 |
| MDXH | MDxHealth SA | $55M | +3.27% | -12.77% | -67.30% | -75.47% | 38 |
| MBAI | MBody AI Ltd. | $48M | -1.06% | -50.68% | -84.68% | -89.62% | 2 |
| PRPO | Precipio, Inc. | $43M | -0.04% | -14.08% | +0.61% | +23.34% | 35 |
| NDRA | ENDRA Life Sciences Inc. | $9M | -9.90% | -5.62% | +20.53% | -13.20% | 52 |
| XWEL | XWELL, Inc. | $8M | -1.96% | -12.85% | -43.91% | -74.20% | 38 |
| CODX | Co-Diagnostics, Inc. | $8M | +3.70% | +1.82% | -93.91% | -98.39% | 74 |
| CDIO | Cardio Diagnostics Holdings Inc. | $6M | -4.59% | -5.56% | -61.45% | -76.09% | 52 |
| ISPC | iSpecimen Inc. | $3M | +4.63% | -27.10% | -89.13% | -97.08% | 14 |
| BJDX | Bluejay Diagnostics, Inc. | $1M | -1.52% | -18.43% | -68.58% | -88.79% | 28 |
Companies classified under the Healthcare & Biotech theme and the Diagnostics, Biomarkers & Liquid Biopsy sub-theme within Next Big Trend's catalog.
Yes. Signed-in users can save the current constituents from this page as a named watchlist.
No. It is a research universe for screening, not a recommendation.